TIANYU PHARM(300702.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
TIANYU PHARM
300702.SZ
Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of anti-hypertensive, anti-asthmatic, hypoglycemic, hypolipidemic, and anticoagulant series. It provides fine chemicals and CDMO services.
2.805 T
300702.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking121/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE2.63%C
    • Profit Margin3.07%C
    • Gross Margin32.44%C
  • Growth ScoreB
    • Revenue YoY15.28%B
    • Net Profit YoY-5.79%C
    • Total Assets YoY-0.75%D
    • Net Assets YoY2.68%C
  • Cash ScoreA
    • Cash Flow Margin614.95%A
    • OCF YoY15.28%B
  • Operating ScoreC
    • Turnover0.48C
  • Debt ScoreC
    • Gearing Ratio42.83%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    TIANYU PHARM: Net profit in the third quarter was 71.4211 million yuan, a year-on-year increase of 123.90%

    Zhitong·
    SZ
    300702
    +0.77%
    Zhitong·
    SZ
    300702
    +0.77%

    TIANYU PHARM: Candesartan Cilexetil Tablets have completed drug registration

    Zhitong·
    SZ
    300702
    +0.77%
    Zhitong·
    SZ
    300702
    +0.77%

    TIANYU PHARM released its performance for the first half of the year, with a net profit attributable to the parent company of 150 million yuan, an increase of 180.96%

    Zhitong·
    SZ
    300702
    +0.77%
    Zhitong·
    SZ
    300702
    +0.77%

    The A-share chemical pharmaceutical sector continues to rise, with TIBET AIM PHARM hitting the limit up, and TIANYU PHARM, CSBIO, Zhendong Pharmaceutical, Menovo, JENKEM, and GuangShengTang following suit

    Zhitong·
    SH
    688356
    -1.24%
    SZ
    300702
    +0.77%
    SH
    603538
    +4.73%
    Zhitong·
    SH
    688356
    -1.24%
    SZ
    300702
    +0.77%
    SH
    603538
    +4.73%

    TIANYU PHARM signed a cooperation agreement with Heilongjiang Fengyou Biotechnology Development Co., Ltd

    Zhitong·
    SZ
    300702
    +0.77%
    Zhitong·
    SZ
    300702
    +0.77%
    © 2026 Longbridge｜Disclaimer